BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lamut A, Peterlin Mašič L, Kikelj D, Tomašič T. Efflux pump inhibitors of clinically relevant multidrug resistant bacteria. Med Res Rev 2019;39:2460-504. [PMID: 31004360 DOI: 10.1002/med.21591] [Cited by in Crossref: 36] [Cited by in F6Publishing: 52] [Article Influence: 12.0] [Reference Citation Analysis]
Number Citing Articles
1 Chaudhari R, Singh K, Kodgire P. Biochemical and Molecular Mechanisms of Antibiotic Resistance in Salmonella spp. Research in Microbiology 2022. [DOI: 10.1016/j.resmic.2022.103985] [Reference Citation Analysis]
2 Felicetti T, Cedraro N, Astolfi A, Cernicchi G, Mangiaterra G, Vaiasicca S, Massari S, Manfroni G, Barreca ML, Tabarrini O, Biavasco F, Cecchetti V, Vignaroli C, Sabatini S. New C-6 functionalized quinoline NorA inhibitors strongly synergize with ciprofloxacin against planktonic and biofilm growing resistant Staphylococcus aureus strains. European Journal of Medicinal Chemistry 2022. [DOI: 10.1016/j.ejmech.2022.114656] [Reference Citation Analysis]
3 Macêdo NS, de Sousa Silveira Z, Cordeiro PPM, Coutinho HDM, Júnior JPS, Júnior LJQ, Siyadatpanah A, Kim B, da Cunha FAB, da Silva MV, Kumar S. Inhibition of Staphylococcus aureus Efflux Pump by O-Eugenol and Its Toxicity in Drosophila melanogaster Animal Model. BioMed Research International 2022;2022:1-8. [DOI: 10.1155/2022/1440996] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Zhou S, Rao Y, Li J, Huang Q, Rao X. Staphylococcus aureus small-colony variants: Formation, infection, and treatment. Microbiological Research 2022;260:127040. [DOI: 10.1016/j.micres.2022.127040] [Reference Citation Analysis]
5 Wang X, Xu X, Zhang S, Chen N, Sun Y, Ma K, Hong D, Li L, Du Y, Lu X, Jiang S. TPGS-based and S-thanatin functionalized nanorods for overcoming drug resistance in Klebsiella pneumonia. Nat Commun 2022;13:3731. [PMID: 35768446 DOI: 10.1038/s41467-022-31500-3] [Reference Citation Analysis]
6 Sen T, Verma NK. Functional Role of YnfA, an Efflux Transporter in Resistance to Antimicrobial Agents in Shigella flexneri. Antimicrob Agents Chemother 2022;:e0029322. [PMID: 35727058 DOI: 10.1128/aac.00293-22] [Reference Citation Analysis]
7 Huang Y, Geng H, Wu Z, Sun L, Ji C, Grimes CA, Feng X, Cai Q. An Ag2S@ZIF-Van nanosystem for NIR-II imaging of bacterial-induced inflammation and treatment of wound bacterial infection. Biomater Sci 2022. [PMID: 35708482 DOI: 10.1039/d2bm00550f] [Reference Citation Analysis]
8 Sundaramoorthy NS, Shankaran P, Gopalan V, Nagarajan S. New tools to mitigate drug resistance in Enterobacteriaceae - Escherichia coli and Klebsiella pneumoniae. Crit Rev Microbiol 2022;:1-20. [PMID: 35649163 DOI: 10.1080/1040841X.2022.2080525] [Reference Citation Analysis]
9 Wan X, Li Q, Olsen RH, Meng H, Zhang Z, Wang J, Zheng H, Li L, Shi L. Engineering a CRISPR interference system targeting AcrAB-TolC efflux pump to prevent multidrug resistance development in Escherichia coli. J Antimicrob Chemother 2022:dkac166. [PMID: 35642356 DOI: 10.1093/jac/dkac166] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Nazarov PA. MDR Pumps as Crossroads of Resistance: Antibiotics and Bacteriophages. Antibiotics 2022;11:734. [DOI: 10.3390/antibiotics11060734] [Reference Citation Analysis]
11 Nassarawa SS, Nayik GA, Gupta SD, Areche FO, Jagdale YD, Ansari MJ, Hemeg HA, Al-Farga A, Alotaibi SS. Chemical aspects of polyphenol-protein interactions and their antibacterial activity. Crit Rev Food Sci Nutr 2022;:1-24. [PMID: 35475717 DOI: 10.1080/10408398.2022.2067830] [Reference Citation Analysis]
12 MacNair CR, Farha MA, Serrano-Wu MH, Lee KK, Hubbard B, Côté JP, Carfrae LA, Tu MM, Gaulin JL, Hunt DK, Hung DT, Brown ED. Preclinical Development of Pentamidine Analogs Identifies a Potent and Nontoxic Antibiotic Adjuvant. ACS Infect Dis 2022;8:768-77. [PMID: 35319198 DOI: 10.1021/acsinfecdis.1c00482] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
13 Jain N, Sk MF, Mishra A, Kar P, Kumar A. Identification of novel Efflux pump inhibitors for Neisseria gonorrhoeae via multiple ligand-based pharmacophores, e-pharmacophore, molecular docking, density functional theory, and Molecular dynamics approaches. Computational Biology and Chemistry 2022. [DOI: 10.1016/j.compbiolchem.2022.107682] [Reference Citation Analysis]
14 Bezerra SR, Bezerra AH, de Sousa Silveira Z, Macedo NS, Dos Santos Barbosa CR, Muniz DF, Sampaio Dos Santos JF, Melo Coutinho HD, Bezerra da Cunha FA. Antibacterial activity of eugenol on the IS-58 strain of Staphylococcus aureus resistant to tetracycline and toxicity in Drosophila melanogaster. Microb Pathog 2022;:105456. [PMID: 35217181 DOI: 10.1016/j.micpath.2022.105456] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Garcia ÍR, de Oliveira Garcia FA, Pereira PS, Coutinho HDM, Siyadatpanah A, Norouzi R, Wilairatana P, de Lourdes Pereira M, Nissapatorn V, Tintino SR, Rodrigues FFG. Microbial resistance: The role of efflux pump superfamilies and their respective substrates. Life Sci 2022;:120391. [PMID: 35149116 DOI: 10.1016/j.lfs.2022.120391] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
16 Samreen, Qais FA, Ahmad I. In silico screening and in vitro validation of phytocompounds as multidrug efflux pump inhibitor against E. coli. Journal of Biomolecular Structure and Dynamics. [DOI: 10.1080/07391102.2022.2029564] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
17 Mahey N, Tambat R, Chandal N, Verma DK, Thakur KG, Nandanwar H. Repurposing Approved Drugs as Fluoroquinolone Potentiators to Overcome Efflux Pump Resistance in Staphylococcus aureus. Microbiol Spectr 2021;9:e0095121. [PMID: 34908453 DOI: 10.1128/Spectrum.00951-21] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
18 Koderi Valappil S, Shetty P, Deim Z, Terhes G, Urbán E, Váczi S, Patai R, Polgár T, Pertics BZ, Schneider G, Kovács T, Rákhely G. Survival Comes at a Cost: A Coevolution of Phage and Its Host Leads to Phage Resistance and Antibiotic Sensitivity of Pseudomonas aeruginosa Multidrug Resistant Strains. Front Microbiol 2021;12:783722. [PMID: 34925289 DOI: 10.3389/fmicb.2021.783722] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
19 Dashtbani-Roozbehani A, Brown MH. Efflux Pump Mediated Antimicrobial Resistance by Staphylococci in Health-Related Environments: Challenges and the Quest for Inhibition. Antibiotics (Basel) 2021;10:1502. [PMID: 34943714 DOI: 10.3390/antibiotics10121502] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
20 Cernicchi G, Felicetti T, Sabatini S. Microbial Efflux Pump Inhibitors: A Journey around Quinoline and Indole Derivatives. Molecules 2021;26:6996. [PMID: 34834098 DOI: 10.3390/molecules26226996] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
21 Lu WJ, Hsu PH, Chang CJ, Su CK, Huang YJ, Lin HJ, Lai M, Ooi GX, Dai JY, Lin HV. Identified Seaweed Compound Diphenylmethane Serves as an Efflux Pump Inhibitor in Drug-Resistant Escherichia coli. Antibiotics (Basel) 2021;10:1378. [PMID: 34827316 DOI: 10.3390/antibiotics10111378] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
22 Rodrigues Dos Santos Barbosa C, Feitosa Muniz D, Silvino Pereira P, Maria de Arruda Lima S, Datiane de Morais Oliveira Tintino C, Cintia Alexandrino de Souza V, Mariana Assis da Silva J, Henrique Sousa da Costa R, Cosmo Andrade Pinheiro J, Maria Lobo Soares de Matos Y, Rose Alencar Menezes I, Gonçalves da Silva T, Manoella de Souza Lima G, Cristina Leal Balbino T, Pinto Siqueira-Júnior J, Assis Bezerra da Cunha F, Douglas Melo Coutinho H, Relison Tintino S. Evaluation of Elaiophylin extracted from Streptomyces hygroscopicus as a potential inhibitor of the NorA efflux protein in Staphylococcus aureus: An in vitro and in silico approach. Bioorg Med Chem Lett 2021;50:128334. [PMID: 34425202 DOI: 10.1016/j.bmcl.2021.128334] [Reference Citation Analysis]
23 Jubair N, Rajagopal M, Chinnappan S, Abdullah NB, Fatima A. Review on the Antibacterial Mechanism of Plant-Derived Compounds against Multidrug-Resistant Bacteria (MDR). Evid Based Complement Alternat Med 2021;2021:3663315. [PMID: 34447454 DOI: 10.1155/2021/3663315] [Cited by in Crossref: 3] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
24 Agreles MAA, Cavalcanti IDL, Cavalcanti IMF. The Role of Essential Oils in the Inhibition of Efflux Pumps and Reversion of Bacterial Resistance to Antimicrobials. Curr Microbiol 2021;78:3609-19. [PMID: 34432112 DOI: 10.1007/s00284-021-02635-1] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
25 Ashwath P, Sannejal AD. The Action of Efflux Pump Genes in Conferring Drug Resistance to Klebsiella Species and Their Inhibition. Journal of Health and Allied Sciences NU 2022;12:24-31. [DOI: 10.1055/s-0041-1731914] [Reference Citation Analysis]
26 Dos Santos Barbosa CR, Scherf JR, de Freitas TS, de Menezes IRA, Pereira RLS, Dos Santos JFS, de Jesus SSP, Lopes TP, de Sousa Silveira Z, de Morais Oliveira-Tintino CD, Júnior JPS, Coutinho HDM, Tintino SR, da Cunha FAB. Effect of Carvacrol and Thymol on NorA efflux pump inhibition in multidrug-resistant (MDR) Staphylococcus aureus strains. J Bioenerg Biomembr 2021;53:489-98. [PMID: 34159523 DOI: 10.1007/s10863-021-09906-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
27 Cedraro N, Cannalire R, Astolfi A, Mangiaterra G, Felicetti T, Vaiasicca S, Cernicchi G, Massari S, Manfroni G, Tabarrini O, Cecchetti V, Barreca ML, Biavasco F, Sabatini S. From Quinoline to Quinazoline-Based S. aureus NorA Efflux Pump Inhibitors by Coupling a Focused Scaffold Hopping Approach and a Pharmacophore Search. ChemMedChem 2021. [PMID: 34032014 DOI: 10.1002/cmdc.202100282] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
28 Monteiro KLC, de Aquino TM, Mendonça Junior FJB. An Update on Staphylococcus aureus NorA Efflux Pump Inhibitors. Curr Top Med Chem 2020;20:2168-85. [PMID: 32621719 DOI: 10.2174/1568026620666200704135837] [Cited by in Crossref: 3] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
29 Moir DT, Opperman TJ, Aron ZD, Bowlin TL. Adjunctive therapy for multidrug-resistant bacterial infections: Type III secretion system and efflux inhibitors. Drug Discov Today 2021:S1359-6446(21)00167-7. [PMID: 33845218 DOI: 10.1016/j.drudis.2021.03.031] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
30 Henderson PJF, Maher C, Elbourne LDH, Eijkelkamp BA, Paulsen IT, Hassan KA. Physiological Functions of Bacterial "Multidrug" Efflux Pumps. Chem Rev 2021;121:5417-78. [PMID: 33761243 DOI: 10.1021/acs.chemrev.0c01226] [Cited by in Crossref: 5] [Cited by in F6Publishing: 19] [Article Influence: 5.0] [Reference Citation Analysis]
31 Liu Y, Tong Z, Shi J, Li R, Upton M, Wang Z. Drug repurposing for next-generation combination therapies against multidrug-resistant bacteria. Theranostics 2021;11:4910-28. [PMID: 33754035 DOI: 10.7150/thno.56205] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 15.0] [Reference Citation Analysis]
32 Gerovac M, Wicke L, Chihara K, Schneider C, Lavigne R, Vogel J. A Grad-seq View of RNA and Protein Complexes in Pseudomonas aeruginosa under Standard and Bacteriophage Predation Conditions. mBio 2021;12:e03454-20. [PMID: 33563827 DOI: 10.1128/mBio.03454-20] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
33 Pica M, Messere N, Felicetti T, Sabatini S, Pietrella D, Nocchetti M. Biofunctionalization of Poly(lactide-co-glycolic acid) Using Potent NorA Efflux Pump Inhibitors Immobilized on Nanometric Alpha-Zirconium Phosphate to Reduce Biofilm Formation. Materials (Basel) 2021;14:670. [PMID: 33535577 DOI: 10.3390/ma14030670] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
34 Dalhoff A. Are antibacterial effects of non-antibiotic drugs random or purposeful because of a common evolutionary origin of bacterial and mammalian targets? Infection 2021;49:569-89. [PMID: 33325009 DOI: 10.1007/s15010-020-01547-9] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
35 Ebbensgaard AE, Løbner-Olesen A, Frimodt-Møller J. The Role of Efflux Pumps in the Transition from Low-Level to Clinical Antibiotic Resistance. Antibiotics (Basel) 2020;9:E855. [PMID: 33266054 DOI: 10.3390/antibiotics9120855] [Cited by in Crossref: 2] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
36 Guieu B, Jourdan JP, Dreneau A, Willand N, Rochais C, Dallemagne P. Desirable drug-drug interactions or when a matter of concern becomes a renewed therapeutic strategy. Drug Discov Today 2021;26:315-28. [PMID: 33253919 DOI: 10.1016/j.drudis.2020.11.026] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
37 Serçinoğlu O, Senturk D, Altinisik Kaya FE, Avci FG, Frlan R, Tomašič T, Ozbek P, Orelle C, Jault JM, Sariyar Akbulut B. Identification of novel inhibitors of the ABC transporter BmrA. Bioorg Chem 2020;105:104452. [PMID: 33212311 DOI: 10.1016/j.bioorg.2020.104452] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
38 Klenotic PA, Moseng MA, Morgan CE, Yu EW. Structural and Functional Diversity of Resistance-Nodulation-Cell Division Transporters. Chem Rev 2021;121:5378-416. [PMID: 33211490 DOI: 10.1021/acs.chemrev.0c00621] [Cited by in Crossref: 6] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
39 Huang Y, Chen Y, Zhang LH. The Roles of Microbial Cell-Cell Chemical Communication Systems in the Modulation of Antimicrobial Resistance. Antibiotics (Basel) 2020;9:E779. [PMID: 33171916 DOI: 10.3390/antibiotics9110779] [Cited by in Crossref: 3] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
40 Mattingly AE, Cox KE, Smith R, Melander RJ, Ernst RK, Melander C. Screening an Established Natural Product Library Identifies Secondary Metabolites That Potentiate Conventional Antibiotics. ACS Infect Dis 2020;6:2629-40. [PMID: 32810395 DOI: 10.1021/acsinfecdis.0c00259] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
41 Jesin JA, Stone TA, Mitchell CJ, Reading E, Deber CM. Peptide-Based Approach to Inhibition of the Multidrug Resistance Efflux Pump AcrB. Biochemistry 2020;59:3973-81. [PMID: 33026802 DOI: 10.1021/acs.biochem.0c00417] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
42 Jewboonchu J, Saetang J, Saeloh D, Siriyong T, Rungrotmongkol T, Voravuthikunchai SP, Tipmanee V. Atomistic insight and modeled elucidation of conessine towards Pseudomonas aeruginosa efflux pump. J Biomol Struct Dyn 2020;:1-10. [PMID: 33025857 DOI: 10.1080/07391102.2020.1828169] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
43 Scherf JR, Barbosa Dos Santos CR, Sampaio de Freitas T, Rocha JE, Macêdo NS, Mascarenhas Lima JN, Melo Coutinho HD, Bezerra da Cunha FA. Effect of terpinolene against the resistant Staphylococcus aureus strain, carrier of the efflux pump QacC and β-lactamase gene, and its toxicity in the Drosophila melanogaster model. Microb Pathog 2020;149:104528. [PMID: 33002597 DOI: 10.1016/j.micpath.2020.104528] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
44 Cannalire R, Mangiaterra G, Felicetti T, Astolfi A, Cedraro N, Massari S, Manfroni G, Tabarrini O, Vaiasicca S, Barreca ML, Cecchetti V, Biavasco F, Sabatini S. Structural Modifications of the Quinolin-4-yloxy Core to Obtain New Staphylococcus aureus NorA Inhibitors. Int J Mol Sci 2020;21:E7037. [PMID: 32987835 DOI: 10.3390/ijms21197037] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
45 Wang Y, Li S, Gong X, Chen Q, Ji G, Liu Y, Zheng F. Characterization of RaeE-RaeF-RopN, a putative RND efflux pump system in Riemerella anatipestifer. Vet Microbiol 2020;251:108852. [PMID: 33069037 DOI: 10.1016/j.vetmic.2020.108852] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
46 Xu Z. 1,2,3-Triazole-containing hybrids with potential antibacterial activity against methicillin-resistant Staphylococcus aureus (MRSA). Eur J Med Chem 2020;206:112686. [PMID: 32795773 DOI: 10.1016/j.ejmech.2020.112686] [Cited by in Crossref: 13] [Cited by in F6Publishing: 26] [Article Influence: 6.5] [Reference Citation Analysis]
47 Song F, Li Z, Bian Y, Huo X, Fang J, Shao L, Zhou M. Indole/isatin-containing hybrids as potential antibacterial agents. Arch Pharm (Weinheim) 2020;353:e2000143. [PMID: 32667714 DOI: 10.1002/ardp.202000143] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
48 Grimsey EM, Fais C, Marshall RL, Ricci V, Ciusa ML, Stone JW, Ivens A, Malloci G, Ruggerone P, Vargiu AV, Piddock LJV. Chlorpromazine and Amitriptyline Are Substrates and Inhibitors of the AcrB Multidrug Efflux Pump. mBio 2020;11:e00465-20. [PMID: 32487753 DOI: 10.1128/mBio.00465-20] [Cited by in Crossref: 12] [Cited by in F6Publishing: 22] [Article Influence: 6.0] [Reference Citation Analysis]
49 Small-Saunders JL, Hagenah LM, Fidock DA. Turning the tide: targeting PfCRT to combat drug-resistant P. falciparum? Nat Rev Microbiol 2020;18:261-2. [PMID: 32300249 DOI: 10.1038/s41579-020-0353-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
50 Colclough AL, Alav I, Whittle EE, Pugh HL, Darby EM, Legood SW, McNeil HE, Blair JM. RND efflux pumps in Gram-negative bacteria; regulation, structure and role in antibiotic resistance. Future Microbiol 2020;15:143-57. [PMID: 32073314 DOI: 10.2217/fmb-2019-0235] [Cited by in Crossref: 20] [Cited by in F6Publishing: 29] [Article Influence: 10.0] [Reference Citation Analysis]
51 Kumar S, Lekshmi M, Parvathi A, Ojha M, Wenzel N, Varela MF. Functional and Structural Roles of the Major Facilitator Superfamily Bacterial Multidrug Efflux Pumps. Microorganisms 2020;8:E266. [PMID: 32079127 DOI: 10.3390/microorganisms8020266] [Cited by in Crossref: 16] [Cited by in F6Publishing: 32] [Article Influence: 8.0] [Reference Citation Analysis]
52 Lira-ricárdez J, Pereda-miranda R. Reversal of multidrug resistance by amphiphilic morning glory resin glycosides in bacterial pathogens and human cancer cells. Phytochem Rev 2020;19:1211-29. [DOI: 10.1007/s11101-019-09631-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]